Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N A Dathan

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Molecular Biology Reports|January 1, 1990
Binding specificity determinants of U1A and U2B'' proteinsD Scherly, W Boelens, N A Dathan, et al.
The EMBO Journal|December 20, 1989
Identification of the RNA binding segment of human U1 A protein and definition of its binding site on U1 snRNAD Scherly, W Boelens, W J van Venrooij, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 1, 1994
Developmental expression of the RET protooncogeneV Avantaggiato, N A Dathan, M Grieco, et al.
Nucleic Acids Research|February 11, 1991
A weak interaction between the U2A' protein and U2 snRNA helps to stabilize their complex with the U2B" proteinW Boelens, D Scherly, R P Beijer, et al.
Oncogene|February 1, 1994
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinomaM Santoro, N A Dathan, M T Berlingieri, et al.
Endocrinology|April 1, 1997
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potentialA M Cirafici, G Salvatore, G De Vita, et al.
Science (New York, N.Y.)|January 20, 1995
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2BM Santoro, F Carlomagno, A Romano, et al.
Oncogene|July 6, 1995
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cellsD Califano, C Monaco, G de Vita, et al.
The Journal of Biological Chemistry|November 15, 1996
Ligand stimulation of a Ret chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2BC Rizzo, D Califano, G L Colucci-D'Amato, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Molecular Biology Reports|January 1, 1990
Binding specificity determinants of U1A and U2B'' proteinsD Scherly, W Boelens, N A Dathan, et al.
The EMBO Journal|December 20, 1989
Identification of the RNA binding segment of human U1 A protein and definition of its binding site on U1 snRNAD Scherly, W Boelens, W J van Venrooij, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 1, 1994
Developmental expression of the RET protooncogeneV Avantaggiato, N A Dathan, M Grieco, et al.
Nucleic Acids Research|February 11, 1991
A weak interaction between the U2A' protein and U2 snRNA helps to stabilize their complex with the U2B" proteinW Boelens, D Scherly, R P Beijer, et al.
Oncogene|February 1, 1994
Molecular characterization of RET/PTC3; a novel rearranged version of the RETproto-oncogene in a human thyroid papillary carcinomaM Santoro, N A Dathan, M T Berlingieri, et al.
Endocrinology|April 1, 1997
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potentialA M Cirafici, G Salvatore, G De Vita, et al.
Science (New York, N.Y.)|January 20, 1995
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2BM Santoro, F Carlomagno, A Romano, et al.
Oncogene|July 6, 1995
Activated RET/PTC oncogene elicits immediate early and delayed response genes in PC12 cellsD Califano, C Monaco, G de Vita, et al.
The Journal of Biological Chemistry|November 15, 1996
Ligand stimulation of a Ret chimeric receptor carrying the activating mutation responsible for the multiple endocrine neoplasia type 2BC Rizzo, D Califano, G L Colucci-D'Amato, et al.
Pageof 2